Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease

Authors:

Abstract
Sir, We read Koduri et al.’s [1] article with great interest. Since publishing our original study [2] we now have a 13- to 15-year follow-up on RA patients with interstitial lung disease (ILD) diagnosed by high-resolution CT (HRCT). As the paper looked at prognosis, we decided to evaluate our own data, looking at death as an outcome. The study had ethical approval from St Helens and Knowsley Research Ethics Committee for the original study and follow-up. We used the Goh et al. HRCT scoring system [3] that has been evaluated in scleroderma. The initial ILD has been converted from the Wells HRCT ILD scoring system [4] to the Goh et al. system as limited (0–20%), borderline (20–25%) or extensive (>25%) involvement.